Exabis Library
Welcome to the e-CCO Library!
DOP003: Gene expression profiling indicates similar molecular pathways are active in adult and paediatric ulcerative colitis
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
DOP003: Gene Expression Profiling Indicates Similar Molecular Pathways Are Active in Adult And Pediatric Ulcerative Colitis
2016
ECCO'16 DOP
1
DOP003: Proximal disease extension in patients with limited ulcerative colitis: a Danish population-based inception cohort
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
DOP003: Proximal disease extension in patients with limited Ulcerative Colitis: a Danish population-based inception cohort
2017
ECCO'17 Barcelona
1
DOP003: Ustekinumab induces clinical and biological remission in biologic refractory Crohn’s disease patients: A real-world belgian cohort study
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
DOP003: Ustekinumab induces clinical and biological remission in biologic refractory Crohn's Disease patients: A real world belgian cohort study
2018
ECCO'18 Vienna
Tuesday, 8 May 2018, 11:36 AM
1
DOP004: Epigenetic control of colonic epithelial antigen processing, barrier function, and the microbiome via methyl-CpG binding domain protein 2
2016
ECCO'16 DOP
1
DOP004: Epigenetic control of colonic epithelial antigen processing, barrier function, and the microbiome via methyl-CpG binding domain protein 2
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
DOP004: Ethnicity and country of birth are associated with phenotypic differences in patients with inflammatory bowel disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
DOP004: Ethnicity and country of birth are associated with phenotypic differences in patients with Inflammatory Bowel Disease
2017
ECCO'17 Barcelona
1
DOP004: Long-term safety of adalimumab in patients with Moderate to Severe Ulcerative Colitis: Interim results of a non-interventional registry, LEGACY
2018
ECCO'18 Vienna
Tuesday, 8 May 2018, 11:36 AM
1
DOP004: Long-term safety of adalimumab in patients with moderate-to-severe ulcerative colitis: Interim results of a non-interventional registry, LEGACY
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
DOP005: A role for IL1 in mediating intestinal inflammation in IL10 receptor deficiency in mice and humans
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
DOP005: Proximal disease extension in limited ulcerative colitis: a systematic review and meta-analysis
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
DOP005: Proximal disease extension in limited Ulcerative Colitis: A systematic review and meta-analysis
2017
ECCO'17 Barcelona
1
DOP005: Safety of vedolizumab in patients naïve to treatment with TNF antagonists compared with patients with prior use of TNF antagonists
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
DOP005: Safety of vedolizumab in patients naïve to treatment with TNF antagonists compared with patients with prior use of TNF antagonists
2018
ECCO'18 Vienna
Tuesday, 8 May 2018, 11:36 AM
1
DOP006: A multicentre cohort study to assess the safety of vedolizumab for inflammatory bowel disease
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
DOP006: A multicentre cohort study to assess the safety of vedolizumab for Inflammatory Bowel Disease
2018
ECCO'18 Vienna
Tuesday, 8 May 2018, 11:36 AM
1
DOP006: Gut homing adipose tissue T-cells might influence intestinal barrier function in Crohn’s disease and obesity
2016
ECCO'16 DOP
1